20
Raks Pharma Pvt Ltd, based in India, is a pharmaceutical company that stands out with its certifications from WHO-GMP.
One of their notable products is FLUPHENAZINE HYDROCHLORIDE USP, with a corresponding US DMF Number 33371.
Remarkably, this DMF maintains an Active status since its submission on November 29, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 08, 2019, and payment made on November 27, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II